FDA Approvals in RCC and CML, Priority Review Designations in NSCLC and RCC, and More
The European Union’s Committee for Medicinal Products for Human Use (CHMP) recommends the approval of Herzuma, a trastuzumab biosimilar, for treating HER2-positive... Read More
